Stay updated on SER-109 for RCDI Prevention Clinical Trial

Sign up to get notified when there's something new on the SER-109 for RCDI Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SER-109 for RCDI Prevention Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T11:41:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding/operating status notice (previously Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T06:16:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Informational updates were made: a government funding lapse notice appears at the top of the page and a new Nat Med reference was added. An older Nat Med citation was removed and the revision version updated.
    Difference
    0.4%
    Check dated 2026-02-04T04:36:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary UI text was added, and footer/tracking metadata was updated (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), replacing older QC-related strings.
    Difference
    0.2%
    Check dated 2026-01-28T02:27:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new publication citation The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome (Nat Med, 2026) has been added to Publications. The page revision was updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:19:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section with state-by-state site listings (California, Florida, Georgia, Idaho, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Texas, Virginia) and a Revision: v3.3.3. Removed individual state location subsections and the HHS Vulnerability Disclosure.
    Difference
    2%
    Check dated 2025-12-23T09:43:20.000Z thumbnail image

Stay in the know with updates to SER-109 for RCDI Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SER-109 for RCDI Prevention Clinical Trial page.